Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the Spero Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time all participants are in listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Kerrisdale Capital Sahm Adrangi | 0 | $0 | 0% | |
2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.54 | 10,000 | Officer, Director | 352,714 | 2013-03-11 | Filing | |
$1.50 | 5,000 | Officer, Director | 342,714 | 2013-03-11 | Filing | |
$1.19 | 22,693 | Large Shareholder | 638,259 | 2012-12-28 | Filing | |
$2.40 | 2,000 | Officer, Director | 152,498 | 2012-12-24 | Filing | |
$1.90 | 4,600 | Director | 48,600 | 2012-09-05 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.41 | 10,000 | Officer | 9,773 | 2011-01-13 | Filing | |
$3.63 | 3,046 | Officer | 19,773 | 2009-11-13 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 0 | $0 | 0% |